Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,495.00
+15.00 (1.01%)
May 27, 2026, 5:02 PM GMT
Hikma Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Hikma Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of 1,899p. The average 1-year stock price forecast is 27.02% higher than the current stock price, while the lowest is 1,352p (-9.58%) and the highest is 2,638p (+76.43%).
Price Target: 1,899p (+27.02%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Hikma Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 6 | 7 | 7 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Reiterates 1,850p → 1,870p | Buy | Reiterates | 1,850p → 1,870p | +25.08% | May 5, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Reiterates 1,800p | Buy | Reiterates | 1,800p | +20.40% | Apr 28, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains 2,000p | Buy | Maintains | 2,000p | +33.78% | Mar 3, 2026 |
| Barclays | Barclays | Sell Maintains 1,350p | Sell | Maintains | 1,350p | -9.70% | Mar 2, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Reiterates 2,500p → 2,400p | Buy | Reiterates | 2,500p → 2,400p | +60.54% | Jan 9, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.